Stocks · Health care · Biological Products, (No Diagnostic Substances)

EXELIXIS, INC.

EXEL Clue Score84
United States Fiscal year ends January CIK 0000939767 Results filed 29 Oct 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Michael Morrissey
13 Feb 2026
President and CEO
Exercised, kept
494,700
$21.31
$10.54M
Michael Morrissey
14 May 2025
President and CEO
Exercised, kept
308,365
$18.80
$5.80M
Jeffrey Hessekiel
27 Nov 2024
EVP & General Counsel
Exercised, kept
129,314
$18.80
$2.43M
Patrick J. Haley
2 Oct 2024
EVP, Commercial
Exercised, kept
100,000
$24.41
$2.44M
Michael Morrissey
1 Oct 2024
President and CEO
Exercised, kept
480,000
$24.41
$11.72M
Michael Morrissey
28 Aug 2023
President and CEO
Exercised, kept
360,000
$15.31
$5.51M
Michael Morrissey
24 Jan 2023
President and CEO
Exercised, kept
100,000
$4.20
$420.00K
Christopher J. Senner
11 Aug 2022
EVP and CFO
Exercised, kept
225,000
$6.21
$1.40M
Christopher J. Senner
21 Sep 2021
EVP and CFO
Exercised, kept
90,000
$3.66
$329.40K
Gisela Schwab
26 Jul 2021
Pres, Prod Dev & Med Aff & CMO
Exercised, kept
40,000
$4.20
$168.00K
Gisela Schwab
21 Jul 2021
Pres, Prod Dev & Med Aff & CMO
Exercised, kept
35,000
$4.20
$147.00K
Charles Cohen
6 Jul 2021
Director
Exercised, kept
40,000
$6.30
$252.00K
Charles Cohen
6 Jul 2021
Director
Exercised, kept
40,000
$3.13
$125.20K
Michael Morrissey
12 May 2021
President and CEO
Exercised, kept
50,000
$4.20
$210.00K
George Poste
22 Feb 2021
Director
Exercised, kept
40,000
$3.38
$135.20K
Jeffrey Hessekiel
4 Jan 2021
EVP and General Counsel
Exercised, kept
20,000
$1.90
$38.00K
Jeffrey Hessekiel
4 Jan 2021
EVP and General Counsel
Exercised, kept
30,000
$7.27
$218.10K
Lance Willsey
4 Dec 2020
Director
Exercised, kept
106,142
$5.82
$617.75K
Jeffrey Hessekiel
15 Nov 2020
EVP and General Counsel
Exercised, kept
30,000
$7.27
$218.10K
Jeffrey Hessekiel
8 Sep 2020
EVP and General Counsel
Exercised, kept
190,000
$6.21
$1.18M
Jeffrey Hessekiel
8 Sep 2020
EVP and General Counsel
Exercised, kept
59,692
$1.90
$113.41K
Charles Cohen
1 Sep 2020
Director
Exercised, kept
115,396
$5.82
$671.60K
George Poste
14 Aug 2020
Director
Exercised, kept
29,662
$5.82
$172.63K
Michael Morrissey
20 Jul 2020
President and CEO
Exercised, kept
100,000
$6.21
$621.00K
Michael Morrissey
10 Jul 2020
President and CEO
Exercised, kept
100,000
$6.21
$621.00K
Michael Morrissey
19 Jun 2020
President and CEO
Exercised, kept
100,000
$6.21
$621.00K
Michael Morrissey
29 May 2020
President and CEO
Exercised, kept
100,000
$6.21
$621.00K
George A Scangos
15 May 2020
Director
Exercised, kept
21,686
$5.82
$126.21K
George A Scangos
15 May 2020
Director
Exercised, kept
30,000
$4.58
$137.40K
Michael Morrissey
15 May 2020
President and CEO
Exercised, kept
100,000
$6.21
$621.00K
Stelios Papadopoulos
13 May 2020
Director
Exercised, kept
120,791
$5.82
$703.00K
Jeffrey Hessekiel
13 May 2020
EVP and General Counsel
Exercised, kept
25,000
$1.70
$42.50K
Michael Morrissey
6 May 2020
President and CEO
Exercised, kept
285,284
$1.70
$484.98K
Michael Morrissey
27 Apr 2020
President and CEO
Exercised, kept
285,000
$1.70
$484.50K
Michael Morrissey
23 Apr 2020
President and CEO
Exercised, kept
250,000
$5.51
$1.38M
Michael Morrissey
21 Apr 2020
President and CEO
Exercised, kept
220,000
$5.51
$1.21M
Michael Morrissey
20 Apr 2020
President and CEO
Exercised, kept
240,000
$5.51
$1.32M
Showing 250 of 499 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 706
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 8
Sales on a Rule 10b5-1 plan 26
Sales straight out of an exercise 283
Sales at will 131
Transactions with no price 0
Shares from compensation/vesting 41,557,913
Sales filed before the plan box existed 101
History held since 6 Oct 2006